M. Haberland

Molecular Biology · 2007–2009

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Haberland trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. PA Marks
  2. Tony Kouzarides
  3. E. Olson
  4. Xiang-Jiao Yang
  5. S. Kurdistani
  6. M. Grunstein
  7. R. Bassel-Duby
  8. Jessica E. Bolden

Who trusts M. Haberland overall

  1. E. Seto
  2. C. Ling

Papers from M. Haberland's perspective

Ordered by how strongly the researchers M. Haberland trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family* (Journal of Biological Chemistry)
  2. Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
  3. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. (Molecules and Cells)
  4. Translating the Histone Code (Science)
  5. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug (Nature Biotechnology)
  6. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer (Nature Reviews. Cancer)
  7. Acetylation: a regulatory modification to rival phosphorylation? (EMBO Journal)
  8. Class II histone deacetylases: versatile regulators. (Trends in Genetics)
  9. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). (Blood)
  10. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression (EMBO Journal)

Their papers